102 results
8-K
AXLA
Axcella Health Inc.
9 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
, following the Board Resignations, it is the Staff’s belief that the Company is no longer in compliance with the majority independent board requirement under … under Listing Rule 5605(d)(2) and the Independent Director oversight of Director Nominations requirement under Listing Rule 5605(e)(1). The Nasdaq
8-K
AXLA
Axcella Health Inc.
11 Sep 23
Submission of Matters to a Vote of Security Holders
4:32pm
” Baird
The stockholders of the Company ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm
PRE 14A
wiqgx
7 Aug 23
Preliminary proxy
4:15pm
8-K
EX-5.1
2u3 eg0c29845d5asv
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
zfe82isiy8mdz4 l1w
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
EX-10.1
tot18f7
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
uh3v otqm9oz
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-99.2
e65eq 30ovn
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
EX-10.1
4hgc3wf4gu914u5wcesh
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.2
762nccz
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
4wyqyx
25 May 22
Departure of Directors or Certain Officers
5:01pm
DEFA14A
cmzlp
7 Apr 22
Additional proxy soliciting materials
4:00pm